Glembatumumab vedotin shows a innovative strategy in tumor treatment. This antibody-drug conjugate selectively recognizes a molecule expressed on various cancer cells, releasing an effective cytotoxic drug. Preliminary medical investigations demonstrate meaningful effect against certain blood-related cancers and is currently being assessed for thei